Specifically, GDF15, a serum biomarker, significantly improved the diagnostic accuracy of Model 4 for arteriosclerosis in patients with OSA (Chi-square increased from 25 to 50). This evidence concerns the gene GDF15 and arteriosclerosis disorder.